Online informed consent tool designed to encourage trial participation

In an attempt to address the problem of extremely low enrollment in cancer clinical trials (among adults the national figure is around 3 percent) researchers from the Perelman School of Medicine at the University of Pennsylvania have created an online multimedia informed consent tool that drew high marks from surveyed physicians.

Acknowledging that the informed consent process is an overwhelming and tedious one, and that it is often addressed at a time when cancer patients are at their most vulnerable, Penn researchers created an online tool that includes downloadable PDF forms as well as a video that will feature a trial investigator discussing the clinical trial at length, in language easier to understand than medical jargon. This will allow the patient to watch and re-watch the video, as well as send the link to others and have them watch the video and get their feedback as well.

In short, the online tool gives the patient the time they need to give the proper consideration to taking part in a clinical trial, giving them all the available information and making as certain as possible that the consent a patient is about to give is truly an informed one.

Said James Metz of Penn Medicine, "We believe our tool can make that process easier for patients and their families, as well as for clinicians, who often struggle to accrue enough patients to complete trials."

The researchers presented the tool, found at the University's cancer care site, OncoLink, at this year's ASTRO meeting.

Source: Medical News Today

More Articles

More Articles

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...